Patent Office Manual: Pre-judging the Novartis-Glivec Case?
In a previous post, Prashant touched upon the brazen way in which the patent manual sought to prejudge the Novartis (Glivec) case. For those of you not familiar with the Novartis patent litigation (given the 100 odd posts that we’ve done so far on this big ticket patent litigation in India, its highly unlikely that our readers may not have come across this till now), here is a brief gist, from a recent paper of ours that was published a…
Read More